Form 4 for RMD ResMed|
Accepted 2023-02-22 00:00:00 ET · period of report 2023-02-17 · accession 0001127602-23-006460 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | 2023-02-17 | RMD | Sandercock Brett | CFO | S - Sale | $215.22 | -10.0K | 106.9K | -9% | -$2.15M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2023-02-17 | S | D | 10,000 | $215.22 | 106,880 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $215.00 - $215.59. The price reported above reflects the weighted average sale price. |